Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16978420 | 1.00 | CYP3A4 (0.36) | CYP3A4CYP2C9APPS1PR1HSP90AA1 | |
| SCHEMBL21019055 | 0.99 | CYP3A4 (0.37) | CYP3A4CYP2C9APPS1PR1HSP90AA1 | |
| SCHEMBL17070200 | 0.99 | CYP3A4 (0.37) | CYP3A4CYP2C9APPS1PR1HSP90AA1 | |
| SCHEMBL16546479 | 0.97 | CYP3A4 (0.33) | CYP3A4CYP2C9APPS1PR1HSP90AA1 | |
| SCHEMBL17147788 | 0.97 | CYP3A4 (0.33) | CYP3A4CYP2C9APPS1PR1HSP90AA1 | |
| SCHEMBL16978449 | 0.95 | CYP3A4 (0.33) | CYP3A4CYP2C9APPS1PR1HSP90AA1 | |
| SCHEMBL16978421 | 0.95 | CYP3A4 (0.33) | CYP3A4CYP2C9APPS1PR1HSP90AA1 | |
| SCHEMBL17070267 | 0.94 | CYP3A4 (0.35) | CYP3A4CYP2C9APPS1PR1HSP90AA1 | |
| SCHEMBL16978458 | 0.94 | CYP3A4 (0.36) | CYP3A4CYP2C9APPS1PR1HSP90AA1 | |
| SCHEMBL16978432 | 0.93 | CYP3A4 (0.31) | CYP3A4CYP2C9APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10457869-B2 | Liquid crystal composition and liquid crystal display device | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2019-10-29 | — | — | US | disclosed |
| US-9994769-B2 | Liquid crystal composition | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO, LTD. (CN) | 2018-06-12 | — | — | US | disclosed |
| US-9994769-B2 | Liquid crystal composition | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO, LTD. (CN) | 2018-06-12 | — | — | US | disclosed |
| US-20180119011-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE THEREOF | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2018-05-03 | — | — | US | disclosed |
| US-20180037818-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2018-02-08 | — | — | US | disclosed |
| US-20170015906-A1 | LIQUID CRYSTAL COMPOSITION | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO, LTD. (CN) | 2017-01-19 | — | — | US | disclosed |
| US-20170015906-A1 | LIQUID CRYSTAL COMPOSITION | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO, LTD. (CN) | 2017-01-19 | — | — | US | disclosed |
| US-9493704-B2 | Cycloheptane derivative and preparation method and use thereof | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) | 2016-11-15 | — | — | US | disclosed |
| US-9493704-B2 | Cycloheptane derivative and preparation method and use thereof | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) | 2016-11-15 | — | — | US | disclosed |
| US-9458381-B2 | Liquid crystal compounds containing deuterium | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) | 2016-10-04 | — | — | US | disclosed |
| US-20160168461-A1 | CYCLOPROPYL-BEARING LIQUID CRYSTAL COMPOUNDS AND MIXTURES | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) | 2016-06-16 | — | — | US | disclosed |
| US-20160168461-A1 | CYCLOPROPYL-BEARING LIQUID CRYSTAL COMPOUNDS AND MIXTURES | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) | 2016-06-16 | — | — | US | disclosed |
| US-9303208-B2 | Liquid crystal compound containing cyclopentyl and difluorometheneoxy linking group, preparation method and application thereof | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) | 2016-04-05 | — | — | US | disclosed |
| US-9303208-B2 | Liquid crystal compound containing cyclopentyl and difluorometheneoxy linking group, preparation method and application thereof | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) | 2016-04-05 | — | — | US | disclosed |
| US-20150252261-A1 | CYCLOHEPTANE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD (CN) | 2015-09-10 | — | — | US | disclosed |
| US-20150252261-A1 | CYCLOHEPTANE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD (CN) | 2015-09-10 | — | — | US | disclosed |
| US-20150218449-A1 | LIQUID CRYSTAL COMPOUND CONTAINING CYCLOPENTYL AND DIFLUOROMETHENEOXY LINKING GROUP, PREPARATION METHOD AND APPLICATION THEREOF | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATRIALS CO., LTD. (CN) | 2015-08-06 | — | — | US | disclosed |
| US-20150218449-A1 | LIQUID CRYSTAL COMPOUND CONTAINING CYCLOPENTYL AND DIFLUOROMETHENEOXY LINKING GROUP, PREPARATION METHOD AND APPLICATION THEREOF | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATRIALS CO., LTD. (CN) | 2015-08-06 | — | — | US | disclosed |
| US-20140312275-A1 | LIQUID CRYSTAL COMPOUNDS CONTAINING DEUTERIUM | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) | 2014-10-23 | — | — | US | disclosed |
| US-20140312275-A1 | LIQUID CRYSTAL COMPOUNDS CONTAINING DEUTERIUM | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) | 2014-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150252261-A1 | CYCLOHEPTANE DERIVATIVE AND PREPARATION METHOD AND USE THEREOF | DHPS, DHCR24, CCNT1 | CYP3A4 1216/4885CYP2C9 1304/4885APP 607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.